Companies / Forte Biosciences, Inc.
Forte Biosciences, Inc.
Nasdaq: FBRXCIK 1419041DALLAS, TX
Financials · FY2019
Ownership
21.2M shares outstanding · as of Aug 7, 2026
Ownership
| Insiders | 0.59% | 125,160 |
| 10%+ / strategic | 5.82% | 1,235,614 |
| Institutions | 64.02% | 13,590,533 |
| Public float | 29.57% | 6,277,780 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 4
View all →| Insider | % of shares | Shares |
|---|---|---|
Wagner Paul A.SEE REMARKS · Director | 0.39% | 83,178 |
Riley Antony ACHIEF FINANCIAL OFFICER | 0.20% | 41,982 |
Gryska David WDirector | — | — |
Vincent Richard GDirector | — | — |
Institutional holders 62
View all →| Holder | Value | % of shares |
|---|---|---|
| $45.73M | 8.32% | |
| $39.84M | 6.88% | |
| $31.00M | 5.64% | |
| $30.81M | 5.60% | |
| $26.98M | 4.66% | |
| $25.99M | 5.76% | |
| $24.61M | 4.47% | |
| $15.88M | 2.74% | |
| $13.29M | 2.30% | |
| $10.91M | 1.88% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | — | $24.62M | +1.2M +1796.03% | 1,222,862 5.76% of shares | medium |
| Q1 2026 as of | Adage Capital Partners Gp, L.L.C. 13F manager | Add | — | $15.97M | +617K +185.00% | 950,000 4.47% of shares | medium |
| Q1 2026 as of | Janus Henderson Group PLC 13F manager | Trim | — | $-6.17M | -238K -16.67% | 1,188,060 5.60% of shares | medium |
| Q2 2026 as of | State Street Corporation 13F manager | Add | — | $5.90M | +278K +547.70% | 328,522 1.55% of shares | medium |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | Add | — | $2.95M | +114K +314.10% | 150,307 0.71% of shares | low |
| Q1 2026 as of | Millennium Management LLC 13F manager | Add | — | $2.36M | +91K +37.01% | 337,983 1.59% of shares | low |
| Q1 2026 as of | Weil Company, Inc. 13F manager | New | — | $641.4K | +25K | 24,765 0.12% of shares | low |
| Q4 2025 as of | Barclays PLC 13F manager | Add | — | $635.1K | +23K +2840.37% | 24,111 0.11% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Alger Associates, Inc. | Passive13G/A | — |
| Janus Henderson Group PLC | Passive13G/A | — |
| Janus Henderson Group PLC | Passive13G/A | — |
| Oliveira Steven Michael | Passive13G/A | — |
| Affinity Asset Advisors, LLC | Passive13G/A | — |
| Point72 Asset Management, L.P. | Passive13G | — |
| Alger Associates, Inc. | Passive13G/A | — |
| Orbimed Advisors LLC | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| FBRX | — | 34962G208 |